Emergence of SARS-CoV-2 with Dual-Drug Resistant Mutations During a Long-Term Infection in a Kidney Transplant Recipient.

Publication Year: 2024

DOI:
10.2147/IDR.S438915

PMCID:
PMC10860503

PMID:
38348230

Journal Information

Full Title: Infect Drug Resist

Abbreviation: Infect Drug Resist

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology & Pharmacy

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure The authors declare no conflicts of interest in this work."

Evidence found in paper:

"This research was supported by Keisuke Nishioka (JSPS KAKENHI grant no. 20K17468, the public promoting association Asano foundation for studies on medicine), Yohei Watanabe (JST MIRAI grant no. JPMJMI22D2, JSPS KAKENHI grant no. 22H02879), Tomo Daidoji (JSPS KAKENHI grant no. 20KK0199 and 21K08510, the Takeda Science Foundation), Masataka Kawamoto (KPUM2122Fellowship), Sayaka Uda (KPUM2121Fellowship), Atsushi Hoshino (Japan Agency for Medical Research and Development, the Research Program on Emerging and Re-emerging Infectious Diseases under 21fk0108481 and 22fk0108523), Yoko Nukui (JSPS KAKENHI grant no. 19K10554), Takaaki Nakaya (JSPS KAKENHI grant no. 21H03184), and Research Support Project for Life Science and Drug Discovery (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS)) from AMED under Grant Number JP22ama121011."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025